Implementation Strategies for Self-Measured Blood Pressure Monitoring in Racially and Ethnically Diverse Populations
- Conditions
- Blood Pressure Monitoring, HomeHypertension
- Registration Number
- NCT06871462
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
This clinical trial aims to assess the impact of patient-focused and clinical-focused implementation strategies on blood pressure control. The investigators will assess the costs of these strategies and how effective they were at safely and equitably increasing home blood pressure monitoring.
- Detailed Description
This study will focus on assessing implementation strategies to increase adoption of self-monitored blood pressure (SMBP) monitoring among low-income, culturally and linguistically diverse patients with hypertension in an urban safety net. The investigators propose a hybrid type 1 effectiveness-implementation trial of implementation strategies to increase use of SMBP monitoring with clinical support in an urban safety net system. 330 patients will be randomized to a low-intensity vs high-intensity implementation strategy for SMBP monitoring. The low-intensity strategy will replicate frequently used implementation efforts (provision of BP monitor with training on using a monitor) while the high-intensity strategy will address additional factors identified in prior work (e.g., digital literacy, social support). In six adult primary clinics, the investigators will concurrently provide a stepped-wedge clinic-level implementation strategy (clinical champions, electronic health record \[EHR\] tools) to increase provision of clinical support for SMBP data. To guide dissemination in other under-resourced settings, an economic evaluation will also be conducted.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 330
- 18 years old/order
- Any sex or gender
- Any race or ethnicity
- Must be receiving primary care at any of the six enrolled clinics
- Have uncontrolled hypertension (BP >=140/90 mmHg at any two encounters in the previous 18 months, including the most recent encounter prior to enrollment)
- Can read and write English, Spanish, or Cantonese
- Be able to provide consent
- Must own a cell phone that receives SMS or text messages
-
Those with conditions that might complicate remote BP monitoring:
- Pregnancy (and 12 months postpartum)
- Acute myocardial infarction or stroke in the last 12 months
- End-stage renal disease on dialysis
- Stage D heart failure
- Active treatment for cancer (except for nonmelanoma skin cancers)
- Pacemaker use
-
Those with dementia, in hospice care, or with serious behavioral health conditions impeding participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in clinic systolic BP Baseline, 12 months, 18 months BP Control Monthly (-6 to 18 months) Clinic patients with EHR recorded BP \< 140/90
- Secondary Outcome Measures
Name Time Method BP Control Baseline, 12 months, 18 months Enrolled participants with controlled BP based on (a) clinic BP values; (b) home BP values
Home Systolic BP (SBP) Baseline, 12 months, 18 months Home SBP for enrolled participants
Patient Adoption 12 months Number of SMBP values per participant
Clinic adoption Monthly (-6 to 18 months) Clinic patients with EHR documented patient reported BP
Reach 12 months Percent of participants who actively participate in SMBP monitoring
Costs During trial; 12 months Costs (including time, equipment, consumables) of SMBP monitoring + implementation strategies
Patient Activation Baseline, 12 months Patient Assessment of Chronic Illness Care (PACIC) - Minimum score: 1, Maximum score: 5. The PACIC is scored by summing participants' responses across all 20 items then dividing by 20, the number of items in the scale. Thus, scores on the PACIC range from 1 to 5 with higher scores indicating a better outcome (patient's perception of greater involvement in self-management and receipt of chronic care counseling).
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Zuckerberg San Francisco Hospital
🇺🇸San Francisco, California, United States